Antibiotic Resistance From The Maxillofacial Surgery Perspective

27th Congress of the Balkan Stomatological Society, İstanbul, Türkiye, 9 - 11 Kasım 2023, ss.61, (Özet Bildiri)

Antibiotic resistance presents a growing challenge in healthcare, and it is of increasing concern in maxillofacial

surgery. Maxillofacial surgeons frequently encounter complex infections and postoperative complications that

necessitate antibiotic use. However, the inappropriate or excessive use of antibiotics in this field can contribute

to the development of antibiotic-resistant bacteria, posing risks to individual patient care and public health.

Odontogenic infections rank among the most common infections in the human body. The β-lactam, macrolide,

lincosamide, nitroimidazole, and tetracycline groups of antibiotics are the most commonly used and effective

options for dental problems. One of the primary factors leading to the development of resistance is the

extended use of antimicrobials when the underlying cause is not adequately treated. These antibiotics

are also employed in the treatment of focal infections and as prophylactic measures. It is evident that this

widespread usage could potentially become a significant public health concern if not applied correctly.

Furthermore, antibiotic resistance carries a substantial economic burden, including prolonged hospital

stays, numerous medical tests, workforce productivity loss, and the necessity for extended and diverse

antibiotic treatments. The extensive application of antibiotics across various sectors leads to the emergence

of antibiotic-resistant bacteria and genes, intensifying resistance levels. To address this global challenge,

proactive measures such as antibiotic stewardship, robust infection control protocols, and patient education

are essential. These strategies aim to promote responsible antibiotic usage within the field of maxillofacial

surgery and help mitigate the overarching problem of antibiotic resistance.